Generation of an infectious cDNA of a highly cardiovirulent coxsackievirus B3(CVB3(m)) and comparison to other infectious CVB3 CDNAs

Virus Research

Volumn 50, Issue 2, 1997, Pages 225-235

  Lee, C ^a   Maull, E ^b   Chapman, N ^c   Tracy, S ^c   Wood, J ^d   Gauntt, C ^d  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b Air Force Materiel Command   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Cardiovirulence; cDNA cloning; Coxsackievirus B3; Molecular evolution; RNA editing; Selective pressure

Indexed keywords

COMPLEMENTARY DNA; EPITOPE; MONOCLONAL ANTIBODY; VIRUS DNA; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVIRUS; CONTROLLED STUDY; COXSACKIE VIRUS B3; MALE; MOUSE; MYOCARDITIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PICORNAVIRUS; POINT MUTATION; PRIORITY JOURNAL; VIRUS NEUTRALIZATION; VIRUS VIRULENCE;

ANIMALS; ANTIGENS, VIRAL; CLONING, MOLECULAR; CONSERVED SEQUENCE; DNA, COMPLEMENTARY; ENTEROVIRUS B, HUMAN; GENOME, VIRAL; HEART; HELA CELLS; HUMANS; MALE; MICE; MICE, INBRED STRAINS; NEUTRALIZATION TESTS; POLYMERASE CHAIN REACTION; SELECTION (GENETICS); SEQUENCE HOMOLOGY, NUCLEIC ACID; TRANSFECTION; VIRULENCE;

ANIMALIA; CARDIOVIRUS; COXSACKIEVIRUS; DNA VIRUSES; MIRIDAE; PICORNAVIRIDAE; RNA VIRUSES;

EID: 0030869507     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(97)00059-2     Document Type: Article

References (50)

1. Agol, V.L., 1991. The 5′-untranslated region of picornaviral genomes. Adv. Virus Res. 40, 103-180.
2. Almond, J.W., 1987. The attenuation of poliovirus neurovirulence. Ann. Rev. Microbiol. 41, 153-180.
3. Arnold, E., Rossman, M.G., 1990. Analysis of the structure of a common cold virus, human rhinovirus 14, refined at a resolution of 3.0 Å. J. Mol. Biol. 211, 763-801.
4. Beck, M.A., Kolbeck, P.C., Rohr, L.H., Shi, Q., Morris, V.C., Levander, O.A., 1994a. Increased virulence of a human enterovirus (coxsackievirus B3) in selenium-deficient mice. J. Infect. Dis. 170, 351-357.
5. Beck, M.A., Kolbeck, P.C., Rohr, L.H., Shi, Q., Morris, V.C., Levander, O.A., 1994b. Vitamin E deficiency intensifies the myocardial injury of coxsackievirus B3 infection of mice. J. Nutr. 124, 345-358.
6. Beck, M.A., Shi, Q., Morris, V.C., Levander, O.A., 1995. Rapid genomic evolution of a non-virulent coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates. Nat. Med. 1, 433-436.
7. Beisel, K.W., Srinivasappa, J., Prabhakar, B.S., 1991. Identification of a putative shared epitope between coxsackievirus B4 and α cardiac myosin heavy chain. Clin. Exp. Immunol. 86, 49-55.
8. Chang, K., Auvinen, P., Hyypia, T., Stanway, G., 1989. The nucleotide sequence of coxsackievirus A9; implications for receptor binding and enterovirus classification. J. Gen. Virol. 70, 3269-3280.
9. Chapman, N.M., Tu, Z., Tracy, S., Gauntt, C.J., 1994. An infectious cDNA copy of the genome of a non-cardiovirulent coxsackievirus B3 strain: Its complete sequence analysis and comparison to the genomes of cardiovirulent coxsackieviruses. Arch. Virol. 135, 115-130.
10. Cranic, R., Couillin, D., Blondel, B., Cabau, N., Boue, A., Horodniceanu, F., 1983. Natural variation of poliovirus neutralization epitopes. Infect. Immun. 41, 1217-1225.
11. Cunningham, M.W., Antone, S.M., Gulizia, J.M., McManus, B.M., Fischetti, V.A., Gauntt, C.J., 1992. Cytotoxic and viral neutralizing antibodies crossreact with streptococcal M protein, enteroviruses and human cardiac myosin. Proc. Natl. Acad. Sci. USA 89, 1320-1324.
12. Domingo, E., Holland, J.J., 1988. High error rates, population equilibrium and evolution of RNA replication systems. In: Domingo, E., Holland, J.J., Ahlquist, P. (Eds.), RNA Genetic vol. 3, CRC, Boca Raton, FL, pp. 3-36.
13. De la Torre, J.C., Holland, J.J., 1990. RNA virus quasispecies populations can suppress vastly superior mutant progeny. J. Virol. 64, 6278-6281.
14. Gauntt, C.J., Trousdale, M.D., LaBadie, D.R.L., Paque, R.E., Nealon, T., 1979. Properties of coxsackievirus B3 variants which are amyocarditic or myocarditic for mice. J. Med. Virol. 3, 207-220.
15. Gauntt, C.J., 1988. The possible role of viral variants in pathogenesis. In: Bendinelli, M., Friedman, H. (Eds.), Coxsackieviruses-A. General Update. Plenum Press, New York, pp. 159-179.
16. Gauntt, C.J., Higdon, A.L., Arizpe, H.M., Tamayo, M.R., Crawley, R., Henkel, R.D., Pereira, M.E., Tracy, S.M., Cunningham, M.W., 1993a. Epitopes shared between coxsackievirus B3 (CVB3) and normal heart tissues contribute to CVB3-induced murine myocarditis. Clin. Immunol. Immunopathol. 68, 129-134.
17. Gauntt, C.J., Higdon, A., Bowers, D., 1993b. What lessons can be learned from animal model studies in viral heart disease?. Scand. J. Infect. Dis. 88 (suppl), 49-65.
18. Gauntt, C.J., Arizpe, H.M., Higdon, A.L., Wood, H.J., Bowers, D.E., Rozek, M.M., Crawley, R., 1995. Molecular mimicry, anti-coxsackievirus B3 neutralizing monoclonal antibodies and myocarditis. J. Immunol. 154, 2983-2995.
19. Gauntt, C.J. Pallansch, M.A., 1996. Coxsackievirus B3 clinical isolates and murine myocarditis. Virus Res. 41, 89-99.
20. Hogle, J.M., Filman, D.J., 1985. Three dimensional structure of poliovirus at 2.9 Å resolution. Science 229, 1358-1365.
21. Huber, S.A., Moraska, A., Cunningham, M.W., 1994. Alterations in major histocompatibility complex association of myocarditis induced by coxsackievirus B3 mutants selected with monoclonal antibodies to group A streptococci. Proc. Natl. Acad. Sci. USA 91, 5543-5547.
22. Huovilainen, A., Hovi, T., Kinnunen, L., Takkinen, K., Ferguson, M., Minor, P.D., 1987. Evolution of poliovirus during an outbreak: Sequential type 3 poliovirus isolates from several persons show shifts of neutralization determinants. J. Gen. Virol. 68, 1373-1378.
23. Jenkins, O., Booth, J.D., Minor, P.D., Almond, J.W., 1987. The complete nucleotide sequence of coxsackievirus B4 and its comparison to other members of Picornaviridae. J. Gen. Virol. 68, 1835-1848.
24. Jukes, T.H., 1980. Silent nucleotide substitutions and molecular evolutionary clock. Science 210, 973-978.
25. Kandolf, R., Hofschneider, P.H., 1985. Molecular cloning of the genome of a cardiotropic coxsackie B3 virus: Full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells. Proc. Natl. Acad. Sci. USA 82, 4818-4822.
26. Klump, W.M., Bergmann, I., Muller, B.C., Ameis, D., Kandolf, R., 1990. Complete nucleotide sequence of infectious coxsackievirus B3 cDNA: Two initial 5′ uridine residues are regained during plus-stranded RNA synthesis. J. Virol. 64, 1573-1583.
27. Knowlton, K.U., Jeon, E.-S., Berkley, N., Wessely, R., Huber, S., 1996. A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3. J. Virol. 70, 7811-7818.
28. Kondo, R., Horai, S., Satta, Y., Takahata, N., 1993. Evolution of hominoid mitochondrial DNA with special reference to the silent substitution rate over the genome. J. Mol. Evol. 36, 517-531.
29. Lindberg, A., Stalhandske, P., Petterson, U., 1987. Genome of coxsackievirus B3. Virology 156, 50-63.
30. Maisch, B., Bauer, E., Cirsi, M., Kocksiek, K., 1993. Cytolytic cross-reactive antibodies directed against the cardiac membrane and viral proteins in coxsackievirus B3 and B4 myocarditis. Circulation 87 (Suppl IV), 49-65.
31. Martino, T.A., Liu, P., Petric, M., Sole, M.J., 1995. Enteroviral myocarditis and dilated cardiomyopathy: A review of clinical and experimental studies. In: Rotbart, H.A. (Ed.), Human Enterovirus Infections. American Society for Microbiology, Washington DC, pp. 291-351.
32. McManus, B.M., Cassling, R.S., Gauntt, C.J., 1987. Immunologic basis of myocardial injury. Cardiovas. Clin. 18, 163-184.
33. Minor, P.D., John, A., Ferguson, M., Icenogle, J.P., 1986. Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccine. J. Gen. Virol. 67, 693-706.
34. Minor, P.D., Dunn, G., 1988. The effect of sequence in the 5′ non-coding region on the replication of polioviruses in the human gut. J. Gen. Virol. 69, 1091-1096.
35. Muckelbauer, J.K., Kremer, M., Minor, I., Diana, G., Dutko, F.J., Groarke, J., Pevear, D.C., Rossman, M.G., 1995. The structure of coxsackievirus B3 at 3.5 Å resolution. Structure 3, 653-667.
36. Palmenberg, A.C., 1989. Sequence alignments of picornaviral capsid proteins, In: Semler, B.L., Ehrenfeld, E. (Eds.), Molecular Aspects of Picornavirus Infection and Detection. American Society for Microbiology, Washington DC, pp. 211-241.
37. Racaniello, V.R., 1988. Poliovirus neurovirulence. Adv. Virus Res. 34, 217-246.
38. Sambrook, J., Fritsch, E.F., Maniatis, T., 1989. Molecular Cloning: A laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
39. Sanger, F., Nicklen, S., Coulson, A.R., 1977. DNA sequencing with chain terminating inhibitors. Proc. Natl. Acad. Sci. USA 74, 5463-5467.
40. Schwimmbeck, P.L., Schultheiss, H.-P., Strauer, B.E., 1989. Identification of a main autoimmunogenic epitope of the adenine nucleotide translocator which crossreacts with coxsackievirus B3: Use in the diagnosis of myocarditis and dilated cardiomyopathy. Circulation 80 (Suppl II), 665-669.
41. Steinhauer, D.A., de la Torre, J.C., Meier, E., Holland, J.J., 1989. Extreme heterogeneity in populations of vesicular stomatitis virus. J. Virol. 63, 2072-2080.
42. Tracy, S., Chapman, N.M., Romero, J., Ramsingh, A., 1996. Genetics of coxsackievirus B cardiovirulence and inflammatory heart muscle disease. Trends Microbiol. 4, 175-179.
43. Tracy, S., 1988. The genome of the group B coxsackieviruses. In: Bendinelli, M., Herman, F., (Eds.), Coxsackievirus. A General Update. Plenum Press, New York, pp. 19-33.
44. Tracy, S., Chapman, N.M., Tu, Z., 1992. Coxsackievirus B3 from an infectious cDNA copy of the genome is cardiovirulent in mice. Arch. Virol. 122, 399-409.
45. Tu, Z., Chapman, N.M., Hufnagel, G., Tracy, S., Romero, J.R., Barry, W.H., Zhao, L., Currey, K., Shapiro, B., 1995. The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5′ non-translated region. J. Virol. 69, 4607-4618.
46. Van Houten, N., Bouchard, P.E., Moraska, A., Huber, S., 1991. Selection of an attenuated coxsackievirus B3 variant, using a monoclonal antibody reactive to myocyte antigen. J. Virol. 65, 1286-1290.
47. Vogel, F., Kopun, M., 1977. Higher frequencies of transitions among point mutations. J. Mol. Evol. 9, 159-180.
48. Woodruff, J.F., Kilbourne, E.D., 1970. The influence of quantitated past weaning undernutrition on coxsackievirus B3 infection of adult mice. I. Viral persistence and increased severity of lesions. J. Infect. Dis. 121, 137-163.
49. Woodruff, J.F., 1980. Viral myocarditis - A review. Am. J. Pathol. 101, 427-479.
50. Zhang, H.Y., Yousef, G.E., Cunningham, L., Blake, N.W., Ou Yang, X., Bayston, T.A., Kandolf, R., Archard, L.C., 1993. Attenuation of a reactivated cardiovirulent coxsackievirus B3: The 5′ nontranslated region does not contain major attenuation determinants. J. Med. Virol. 41, 129-137.